Residual Macrovascular Risk in 2013: What Have We Learned?

Cardiovascular Diabetology - United Kingdom
doi 10.1186/1475-2840-13-26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EuReCa_Serbia: What Have We Learned?

Journal Resuscitatio Balcanica
2019English

What Have We Learned, So Far?

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2002English

Living With Genetic Risk of Breast Cancer: What Have We Learned?

Breast Cancer Research
Cancer ResearchOncology
2008English

What We Have Learned and How We May Proceed

International Studies in Entrepreneurship
2020English

What We Have Learned From Ribosome Structures

Biochemical Society Transactions
Biochemistry
2008English

Functional Connectivity Studies in Migraine: What Have We Learned?

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2019English

What Have We Learned About Gender Differences in ICT?

Gender Differences in Computer and Information Literacy
2019English

Aflatoxin Resistance in Maize: What Have We Learned Lately?

Advances in Botany
2014English

Two Decades of IDPs; What Have We Learned?

Biophysical Journal
Biophysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy